Skip to main content
. 2021 Aug 13;25(2):89–98. doi: 10.1093/ijnp/pyab056

Table 2.

Clinical Characteristics

BD (n = 75)
BD-I 26 (35%)
BD-II 23 (31%)
BD-NOS 26 (35%)
Age of onset 14.81 ± 2.66
Lifetime clinical characteristics
Lifetime psychosis 8 (11%)
Lifetime suicide attempts 12 (16%)
Lifetime self-injurious behaviour 38 (51%)
Lifetime suicidal ideation 47 (63%)
Legal history (police contact/arrest) 19 (25%)
Lifetime physical abuse 2 (3%)
Lifetime sexual abuse 3 (4%)
Lifetime any abuse (physical and/or sexual) 4 (5%)
Lifetime psychiatric hospitalization 37 (49%)
Lifetime comorbid diagnoses
ADHD 37 (49%)
Anxiety disorder 61 (81%)
Number of anxiety disorders 1.63 ± 1.21
Conduct disorder 3 (4%)
Oppositional defiant disorder 19 (25%)
Substance use disorder 17 (23%)
Nicotine use 11 (15%)
Lifetime medications
Second generation antipsychotics 55 (73%)
Lithium 19 (25%)
Non-SSRI antidepressants 14 (19%)
SSRI antidepressant 25 (33%)
Stimulants 16 (21%)
Current medications
Second generation antipsychotics 44 (59%)
Lithium 14 (19%)
Non-SSRI antidepressants 4 (5%)
SSRI antidepressants 7 (9%)
Stimulants 5 (7%)
Family psychiatric history
Mania/hypomania 36 (48%)
Depression 55 (73%)
Anxiety 46 (61%)
ADHD 25 (33%)

Abbreviations: ADHD, attention deficit-hyperactivity disorder; BD, bipolar disorder; HC, healthy control; NOS, not otherwise specified; SSRI, selective serotonin reuptake inhibitor.

Results are reported in mean ± SD or percentage (%) yes unless otherwise specified.